v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 103 $ 20
Prepaid expenses 1,116 576
Total current assets 1,219 596
Property and equipment, net 750 750
Total assets 1,969 1,346
Current liabilities:    
Accounts payable 6,423 5,912
Accrued expenses 1,190 739
Promissory notes 2,767 3,517
Total current liabilities 10,380 10,168
Related party loan 16,915 11,928
Total liabilities 27,295 22,096
Commitments and contingencies (See Note 4)
Stockholders' deficit:    
Preferred stock, $0.0001 par value, 45,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 5,423,606 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 1 1
Common stock, $0.0001 par value, 740,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; 230,209,142 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 23 23
Additional paid-in capital 255,026 255,026
Accumulated deficit (280,376) (275,800)
Total stockholders' deficit (25,326) (20,750)
Total liabilities and stockholders' deficit $ 1,969 $ 1,346